Kerry Establishes New Biotechnology Centre in Leipzig
Centre to facilitate cutting-edge innovations with wide range of applications across food, beverage and pharma
Advertisement
Kerry has inaugurated the Kerry biotechnology Centre in Leipzig, Germany, which will focus on the development of innovative biotech solutions across food, beverage, and pharma applications.
New capabilities in biotechnology are opening the field to discoveries and opportunities for innovative market solutions that can increase efficiencies across a range of food production processes, overcome ingredient scarcity, and create products tailored to precise needs - improving human health and product functionality.
Kerry has significantly developed its biotechnology capabilities recently, having built a dedicated technology and manufacturing footprint through a combination of strategic acquisitions and organic investment. The Biotechnology Centre in Leipzig will further enhance Kerry’s global infrastructure in this space.
Leipzig has been chosen as the location for the new facility, given the exceptional biotechnology skills base and research cluster that has developed in the city. c-LEcta, which was acquired by Kerry in 2022 for its specialist capabilities in enzymes and biotechnology, was itself established in 2004 as a spin-out from the University of Leipzig.
Kerry’s biotechnology research and production infrastructure spans three continents and is led and co-ordinated from Kerry’s Global Innovation Centre in Ireland. Aligned with the Group's sustainable nutrition strategy, the new Biotechnology Centre in Leipzig will be directed by Dr. Marc Struhalla, the founder of c-LEcta, and will draw on the work of over 100 scientists and technical experts, including 34 PhDs based in the centre. The primary activities that will be undertaken at the new facility include enzyme and strain identification and engineering, fermentation and bioprocess development and scale-up, and production. Novel enzymes are selected from nature, and can then be tailored to perform specific functions with applications in a broad spectrum of use cases.
Following the opening in Leipzig, Kerry CEO, Edmond Scanlon said: “Biotechnology solutions present a new horizon of innovation and opportunity for global food, beverage and pharmaceutical markets. Kerry’s existing portfolio of biotech capabilities, which has been built up over the past 20 years, together with this new Biotechnology Centre, enables us to play a leading role in bringing the next generation of discoveries in this space to market, supporting our customers, as they meet consumer needs for sustainable nutrition”.
Other news from the department business & finance
Most read news
More news from our other portals
Last viewed contents
Laboratory innovations and expert knowledge at analytica 2026 - Key topics: digitalization, automation, sustainability
BASF and IFF announce strategic collaboration to drive next-generation enzyme and polymer innovation
Smartbax secures 4.7 million euros in Pre-Series A funding for the further development of a novel antibiotic up to preclinical stage - Lead candidate against a novel target in Gram-negative bacteria has already been validated in infection models
FIRST LABS - Laboratory start-up support for start-ups - The Rock Capital Group is expanding its concept of ready-to-use laboratories in the life science hub at SKYGATE in Hallbergmoos, especially for start-ups and smaller companies
From beer to useful fats and medicines - The spent grain from beer brewing can be used to make microcapsules that can preserve omega-3 oils and medicines
AI models for drug design fail in physics
Targeted protein degradation: Researchers find new way to combat harmful proteins in tumour cells - Domino effect in the fight against cancer
Chemistry meets biology: controlling artificial cell membranes through catalysis - Researchers develop an artificial metalloenzyme-based platform that enables programmable control of artificial membrane behavior
QIAGEN to acquire Parse Biosciences - Entering the age of single-cell AI
Setting the Course for AI-Assisted Radiology - Fraunhofer MEVIS and Radboud University Medical Center have founded the spin-off Plain Medical
Ancient viral DNA shapes modern human placentas - “It’s a reminder that there is much more to learn about our genome and how ancient infections can influence who we are today”
